messages in brief | 16/12/2021

General Information about the coronavirus, questions and answers, news about the current COVID-19 situation can be found on the website of the Federal Ministry of Health, the Austrian Agency for Health and Food Safety and the Austrian Medical Chamber.

Immunization recommendations of the Austrian National Vaccination Committee (NIG) see "Fachinformationen"

For current measures, visit the Department of Health website.

Product information of authorised COVID-19 vaccines, please refer to the Union Register of medicinal products.

Current status of vaccine approvals is available on the EMA site.

Information on the BASG-Website:

13.12.2021: COVID-19 Vaccines (Comirnaty)

09.12.2021: COVID-19 Vaccines (Spikevax)

25.11.2021: COVID-19 Vaccines (Comirnaty)

24.11.2021: COVID-19 Vaccines (Spikevax)

15.11.2021: COVID-19 Vaccines (Spikevax)

05.11.2021: COVID-19 Vaccines (Comirnaty)

29.10.2021: COVID-19 Vaccines (Spikevax)

20.10.2021: COVID-19 Vaccines (Vaxzevria)

13.10.2021: COVID-19 Vaccines (Janssen)

12.10.2021: COVID-19 Vaccines (Spikevax)

08.10.2021: COVID-19 Vaccines (Comirnaty)

30.09.2021: COVID-19 Vaccines (Janssen)

24.09.2021: COVID-19 Vaccines (Comirnaty)

15.09.2021: COVID-19 Vaccines (Vaxzevria)

13.09.2021: COVID-19 Vaccines (Comirnaty)

06.09.2021: COVID-19 Vaccines (Janssen)

24.08.2021: COVID-19 Vaccines (Spikevax)

29.07.2021: COVID-19 Vaccines (Comirnaty)

26.07.2021: COVID-19 Vaccines (Spikevax)

22.07.2021: COVID-19 Vaccines (Janssen)

19.07.2021: COVID-19 Vaccines (Vaxzevria)

14.07.2021: COVID-19 Vaccines (Spikevax)

14.07.2021: COVID-19 Vaccines (Janssen)

14.07.2021: COVID-19 Vaccines (Comirnaty)

01.07.2021: COVID-19 Vaccines (Vaxzevria)

30.06.2021: COVID-19 Vaccines (Janssen)

22.06.2021:COVID-19 Vaccines (Spikevax)

18.06.2021: COVID-19 Vaccines (Vaxzevria)

17.06.2021: COVID-19 Vaccines (Moderna)

08.06.2021:Current vaccine list

07.06.2021: COVID-19 Vaccines (Moderna)

07.06.2021: safety of SoHO (Substances of Human Orgin)

28.05.2021:COVID-19 Vaccines (Comirnaty)

26.05.2021:COVID-19 Vaccines (Vaxzevria)

07.05.2021: COVID-19 Vaccines (Janssen)

07.05.2021: COVID-19 Vaccines (Moderna)

28.04.2021:COVID-19 Vaccines (Vaxzevria)

22.04.2021: COVID-19 Vaccines (Janssen)

22.04.2021: COVID-19 Vaccines (Comirnaty)

16.04.2021:COVID-19 Vaccines (Vaxzevria)

15.04.2021:COVID-19 Vaccines (Comirnaty)

08.04.2021:COVID-19 Vaccines (Vaxzevria)

30.03.2021: COVID-19 Vaccines (Vaxzevria)

30.03.2021: COVID-19 Vaccines (Comirnaty)

24.03.2021: FAQ on the use of AstraZeneca's vaccine

23.03.2021: COVID-19 Vaccines (Moderna)

22.03.2021: Warning against the use of ivermectin for the treatment of COVID-19

19.03.2021: Release of the temporarily put on hold vaccine batch (AstraZeneca)

18.03.2021:Current vaccine list

15.03.2021: COVID-19 Vaccines (Janssen)

11.03.2021: COVID-19 Vaccines

11.03.2021: COVID-19 Convalescent Plasma

07.03.2021: Incidents after vaccination with AstraZeneca's COVID-19 vaccine

04.03.2021: COVID-19 Vaccines (Comirnaty)

09.02.2021: Current vaccine list

09.02.2021: Self-commitment regarding the placing on the market of SARS-CoV-2 rapid tests

05.02.2021: Warning against counterfeit COVID-19 mRNA vaccine "Comirnaty" 

29.01.2021: COVID-19 Vaccines (AstraZeneca)

25.01.2021: Self-commitment regarding the placing on the market of SARS-CoV-2 rapid tests

13.01.2021: Summary of product characteristics of vaccines against COVID-19

12.01.2021: Authorisation of a second vaccine against COVID-19 (Moderna)

22.12.2020: First marketing authorisation of a COVID-19 Vaccine (BioNTech)

03.12.2020: Update of the European Commission regarding CCP (COVID-19 Convalescent Plasma)

12.11.2020: Versorgung mit Arzneimitteln zur COVID-19 Therapie

15.10.2020 : COVID-19 Tests - Abgrenzung und Zuständigkeiten

29.09.2020: Update of the European Commission regarding COVID-19

24.09.2020: COVID-19 Tests - Abgrenzung und Zuständigkeiten

23.09.2020: Versorgung mit Arzneimitteln zur COVID-19 Therapie

31.08.2020: Remdesivir treatment of patients with severe COVID-19

30.06.2020: RMS NEWS

30.06.2020: “RMS-NEWS” published again!

29.05.2020: COVID-19: Reminder on the risks of chloroquine and hydroxychloroquine

25.06.2020: First COVID-19 treatment recommended for EU marketing authorisation

24.06.2020: COVID-19: Warning regarding vor dubios  products advertised as „effective against COVID-19“

22.05.2020: Solnatide treatment of ARDS caused by severe COVID-19

19.05.2020: Legal basis: Ordinances in relation to the Corona virus

18.05.2020: Marketing authorisation and life-cycle: Regulatoriy flexibility during the Corona-pandemic

14.05.2020: Supply with medicinal products for COVID-19 therapy

14.05.2020: COVID-19: Informationen regarding medical devices für companies

14.05.2020: Adverse events and reactions related to cryopreservation of stem cell products during the COVID-19 pandemic

30.04.2020: COVID-19: reporting of adverse reactions

24.04.2020: COVID-19: Warning egarding the risks of serious adverse reactions of chloroquine and hydroxychloroquine

22.04.2020: COVID-19: Regulatory flexibility

20.04.2020: Optimal supply with medicinal products for COVID 19 therapy

14.04.2020: Information of international expert organisations on COVID-19 and blood and tissues

02.04.2020: COVID-19: Warning against wrong use of chloroquine

27.03.2020: Continue medicinal treatment of high blood pressure, heart or kidnex diseasesduring COVID-19 pandemic

24.03.2020: COVID-19: Warning regarding falsified medicinal products distributed by illegal online pharmacies

24.03.2020: Update: Blood & tissues and COVID-19

18.03.2020: Use of ibuprofen and other non-steroidal inflammation inhibtors during COVID-19

17.03.2020: Update: COVID-19 – changes for clinical trials

17.03.2020: Frequently asked questions on ongoing clinical trials during the COVID-19 pandemic

17.03.2020: Clinical trials and COVID-19

16.03.2020: COVID-19 and clinical research

16.03.2020: Update: Blood & tissues and COVID-19

11.03.2020: Blood safety, donor selection citeria and blood supply during the COVID-19 pandemic

10.03.2020: Notification on the possible impact of COVID-19 on the medicines supply

21.01.2020: Novel-Corona Virus (2019-nCoV)


Further inquiry note